AXSOME THERAPEUTICS INC. - COMMON STOCK
121.91
14-March-25 15:45:00
15 minutes delayed
Stocks
+0.26
+0.21%
Today's range
120.52 - 123.47
ISIN
N/A
Source
NASDAQ
-
01 Sep 2022 06:00:00 By Nasdaq GlobeNewswire
-
19 Aug 2022 05:45:03 By Nasdaq GlobeNewswire
-
Axsome Therapeutics Reports Second Quarter 2022 Financial Results and Provides Business Update
09 Aug 2022 06:00:01 By Nasdaq GlobeNewswire
-
Axsome Therapeutics to Report Second Quarter 2022 Financial Results on August 9, 2022
28 Jul 2022 06:00:02 By Nasdaq GlobeNewswire
-
Axsome Therapeutics Hosts Sunosi® Investor Update Virtual Event Today with Key Opinion Leaders
28 Jun 2022 06:00:00 By Nasdaq GlobeNewswire
-
Axsome Therapeutics to Host Sunosi® Investor Update Virtual Event
22 Jun 2022 06:00:01 By Nasdaq GlobeNewswire
-
02 Jun 2022 06:00:01 By Nasdaq GlobeNewswire
-
31 May 2022 06:39:37 By Nasdaq GlobeNewswire
-
09 May 2022 07:57:19 By Nasdaq GlobeNewswire
-
28 Mar 2022 05:00:00 By Nasdaq GlobeNewswire
-
Axsome Therapeutics to Participate in the 1st Annual Needham Virtual Neuroscience Forum
11 Mar 2022 06:00:00 By Nasdaq GlobeNewswire
-
Axsome Therapeutics to Present at the Cowen 42nd Annual Health Care Conference
02 Mar 2022 06:00:01 By Nasdaq GlobeNewswire
-
01 Mar 2022 06:00:02 By Nasdaq GlobeNewswire
-
Axsome Therapeutics to Report Fourth Quarter and Full Year 2021 Financial Results on March 1, 2022
15 Feb 2022 06:00:01 By Nasdaq GlobeNewswire
-
Axsome Therapeutics to Present at the 11th Annual SVB Leerink Global Healthcare Conference
11 Feb 2022 06:00:00 By Nasdaq GlobeNewswire
-
Axsome Therapeutics Reports Third Quarter 2021 Financial Results and Provides Business Update
08 Nov 2021 06:00:01 By Nasdaq GlobeNewswire
-
Axsome Therapeutics to Report Third Quarter 2021 Financial Results on November 8, 2021
20 Oct 2021 06:00:01 By Nasdaq GlobeNewswire
-
Axsome Therapeutics Expands Term Loan Facility with Hercules Capital to $300 Million
18 Oct 2021 06:00:00 By Nasdaq GlobeNewswire